Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

(2015) MARC DE HERT et al.   World Psychiatry

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

(2015) MARC DE HERT et al.   World Psychiatry

A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia

(2011) Jari Tiihonen et al.   AMERICAN JOURNAL OF PSYCHIATRY

Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis

(2011) Alex J. Mitchell et al.   BRITISH JOURNAL OF PSYCHIATRY

Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London

(2011) Chin-Kuo Chang et al.   PLoS One

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

(2011) A. J. Mitchell et al.   PSYCHOLOGICAL MEDICINE

Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs

(2010) Elaine H. Morrato et al.   ARCHIVES OF GENERAL PSYCHIATRY

Statins and All-Cause Mortality in High-Risk Primary Prevention

(2010) Kausik K. Ray   ARCHIVES OF INTERNAL MEDICINE

Twenty-five year mortality of a community cohort with schizophrenia

(2010) Steve Brown et al.   BRITISH JOURNAL OF PSYCHIATRY

Review: Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?

(2010) Hiram Joseph Wildgust et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Review: Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis

(2010) Alex J Mitchell et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Somatic Hospital Contacts, Invasive Cardiac Procedures, and Mortality From Heart Disease in Patients With Severe Mental Disorder

(2009) Thomas Munk Laursen et al.   ARCHIVES OF GENERAL PSYCHIATRY

Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare

(2009) Stephen Kisely et al.   BRITISH JOURNAL OF PSYCHIATRY

Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors

(2009) Amy M. Kilbourne et al.   GENERAL HOSPITAL PSYCHIATRY

Mortality in patients with schizophrenia

(2009) Debasish Basu et al.   LANCET

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Cigarette Smoking and Mortality Risk in People With Schizophrenia

(2009) D. L. Kelly et al.   SCHIZOPHRENIA BULLETIN

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Statins and diabetes – Authors' reply

(2008) Patricia M Kearney et al.   LANCET

The validity of schizophrenia diagnosis in the Finnish Hospital Discharge Register: Findings from a 10-year birth cohort sample

(2008) Johanna Pihlajamaa et al.   NORDIC JOURNAL OF PSYCHIATRY